A detailed history of Flynn Zito Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Flynn Zito Capital Management, LLC holds 7,158 shares of PFE stock, worth $185,320. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,158
Previous 13,541 47.14%
Holding current value
$185,320
Previous $378,000 45.24%
% of portfolio
0.1%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $176,809 - $200,362
-6,383 Reduced 47.14%
7,158 $207,000
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $108,441 - $127,072
-4,293 Reduced 24.07%
13,541 $378,000
Q1 2024

Apr 30, 2024

SELL
$25.89 - $29.73 $42,381 - $48,668
-1,637 Reduced 8.41%
17,834 $494,000
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $23,046 - $29,935
-882 Reduced 4.33%
19,471 $560,000
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $45,278 - $52,926
1,411 Added 7.45%
20,353 $675,000
Q2 2023

Aug 02, 2023

BUY
$36.12 - $41.79 $3,720 - $4,304
103 Added 0.55%
18,942 $694,000
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $35,923 - $46,767
-912 Reduced 4.62%
18,839 $768,000
Q4 2022

Jan 27, 2023

SELL
$41.75 - $54.5 $25,718 - $33,572
-616 Reduced 3.02%
19,751 $1.01 Million
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $891,259 - $1.09 Million
20,367 New
20,367 $891,000
Q2 2022

Jul 28, 2022

SELL
$46.53 - $55.17 $919,991 - $1.09 Million
-19,772 Closed
0 $0
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $411 - $510
9 Added 0.05%
19,772 $1.02 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $816,607 - $1.21 Million
19,763 New
19,763 $1.16 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Flynn Zito Capital Management, LLC Portfolio

Follow Flynn Zito Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flynn Zito Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flynn Zito Capital Management, LLC with notifications on news.